Sunday, August 2, 2026
Science

New biosynthesis platform could enable bioactive compounds to be labeled, targeted and released on demand

Many medically important drugs originate from natural sources. Microorganisms produce these compounds using highly sophisticated and remarkably precise enzymatic assembly lines. Many natural microbial products belong to a class known as nonribosomal peptides—short chains of amino acids that often po...

New biosynthesis platform could enable bioactive compounds to be labeled, targeted and released on demand
Image: Phys.org
Many medically important drugs originate from natural sources. Microorganisms produce these compounds using highly sophisticated and remarkably precise enzymatic assembly lines. Many natural microbial products belong to a class known as nonribosomal peptides—short chains of amino acids that often possess pharmacologically relevant biological activities, including antibiotic effects.

Originally published at Phys.org

The Morning Briefing

Subscribe to our Newsletter

Be the first to receive the latest news, market analysis and updates — delivered straight to your inbox.